Nitric oxide donor hybrid compounds as promising anticancer agents

Drug Discov Ther. 2017 Jan 15;10(6):276-284. doi: 10.5582/ddt.2016.01067. Epub 2016 Dec 18.

Abstract

Nitric oxide (NO) plays important roles in cardiovascular regulation, nerve transmission delivery and immune responses. In the last semicenturry, it has been proved that though low concentration of NO is tumor-promoting, high concentration of NO could exhibit multiple antitumor effects, which led to the research and development of kinds of NO donors and NO donor hybrid compounds as antitumor agents. Herein, the recent development of NO donor hybrid compounds is briefly reviewed.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Humans
  • Nitric Oxide Donors / chemistry*
  • Nitric Oxide Donors / pharmacology

Substances

  • Antineoplastic Agents
  • Nitric Oxide Donors